Stock Ticker

  • Loading stock data...

Nasdaq Considering Launching Its Own Cryptocurrency Exchange But Must Consider Regulations

Nasdaq has been keeping a close eye on events in the digital currency industry. Nasdaq CEO Adena Friedman now says the company may consider running its own cryptocurrency in the future. The wave of digital currency has been sweeping around the world and has attracted the attention of financial regulators and governments alike. It may […]

Catalyst Biosciences Inc (NASDAQ:CBIO) Announces Helpful Factor IX Clinical Data

Catalyst Biosciences Inc (NASDAQ:CBIO) announced recently that they have successfully achieved the positive clinical data from its ongoing Phase 1/2 clinical data in the participants with severe hemophilia B condition. The team was excited by the results that showed the higher potency and advanced pharmacokinetics of CB 2679d. The findings have numerous advantages over the […]

ImmunoGen, Inc. (NASDAQ:IMGN) and Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) Collaborates To Build ADC Molecule

ImmunoGen, Inc. (NASDAQ:IMGN) announced recently that they are entering into a partnership and option agreement with Jazz Pharmaceuticals plc –Ordinary Shares (NASDAQ:JAZZ) to develop and commercialize the stage two, hematology-related Antibody-Drug Conjugate (ADC) programs in addition to another program that will be authorized within the terms of agreement. The programs will cover the IMGN779- CD33-targeting […]

Delcath Systems, Inc. (NASDAQ:DCTH) Closes In Green

In the last trading session, the stock price of Delcath Systems, Inc. (NASDAQ:DCTH) jumped more than 17% to close the day at $0.122. After the recent gains, the market cap of firm now stands at $60.63 million. More recently, the company congratulated the team at the renowned Medical University of Hannover Hospital on their exception […]

The Preclinical Influenza Nanoparticle Study By Novavax, Inc (NASDAQ:NVAX) Published In Vaccine

The stock of Novavax, Inc (NASDAQ:NVAX) closed at $1.06 maintaining the same standing in yesterday’s trading session. This provider has today made an announcement regarding the publication of data from a preclinical study of its nanoparticle influenza vaccine candidate with its proprietary Matrix-M(TM) adjuvant (NanoFlu(TM)) in the journal Vaccine. It is directing a lot of […]

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Appoints New Chief Financial Officer

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) announced recently that it has augmented its executive management team with the addition of Jean M. Franchi as the new Chief Financial Officer (CFO) effective August 21, 2017. Ms. Franchi will take up the role of planning and overseeing the overall financial activities of the company to significantly support the continuous […]

CytRx Corporation (NASDAQ:CYTR) Plans To Avoid Delisting From NASDAQ

CytRx Corporation (NASDAQ:CYTR) reported that it has submitted a preliminary proxy statement with the SEC pertaining to a planned special meeting of shareholders to authorize the company’s Board to follow a reverse stock split of the firm’s common stock, if seen necessary. It may allow the firm to regain compliance with NASDAQ’s $1 minimum bid […]

Tandem Diabetes Care Inc (NASDAQ:TNDM) Begins Enrollment In Pivotal Trial For First Touchscreen Insulin Pump With Predictive Low Glucose Suspend (PLGS)

Tandem Diabetes Care Inc (NASDAQ:TNDM) has announced that it has enrolled its first patient in its trial for its t:slim X2™ Insulin Pump using the company’s predictive low glucose suspend (PLGS) technology. Tandem Diabetes Care is engaged in the manufacture of medical devices as well as touchscreen insulin pumps which are supplied in the United […]

MannKind Corporation (NASDAQ:MNKD) And One Drop To Strike A Collaboration To Help Diabetes Patients

MannKind Corporation (NASDAQ:MNKD) made an announcement about its collaboration with One drop revealing that they were going to engage in a randomized controlled trial. This will be in a bid to investigate the use of Afrezza inhaled insulin. One Drop’s integrated digital diabetes care platform will also be scrutinized further in an effort to identify the […]

What Is The Buzz Surrounding Amarin Corporation plc (ADR)(NASDAQ:AMRN)?

Amarin Corporation plc (ADR)(NASDAQ:AMRN) reported that the data monitoring committee has completed its assessment of the planned pre-specified interim safety and efficacy evaluation for the REDUCE-IT cardiovascular outcomes trial and has recommended that the study continue as planned without any changes. The details As REDUCE-IT is the preliminary prospective clinical study of any treatment in […]

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Announces Gregory Naeve As Chief Business Officer

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) reported that the company has appointed Gregory Naeve, Ph.D., as Chief Business Officer. Dr. Naeve will lead portfolio and product strategy and business development for the firm. The details Rick Fair, the CEO and President of Bellicum, reported that they are thrilled to welcome a leader of Dr. Naeve’s caliber and […]

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) Failed Cannabidiol Trial Saw GW Pharma Head To The Right Direction After Becoming The Best Alternative Cannabidiol Developing Company

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) stocks have downed by 58.5% and according to close sources this is a heaver blow on it trading due to the fact that recently, the company failed to show that the cannabidiol gel could work as far as the intended purposes were concerned. According to Paul Matteis, who is the Leerink […]

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Reports Initiation Of ZENITH-1

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) reported the dosing of the first subject into its clinical study of ZENITH-1. This study is assessing up to 3 dosage strengths of BCX7353 administered as a single oral dose targeting acute treatment of angioedema attacks in people with hereditary angioedema. The details Jon Stonehouse, the Chief Executive Officer of BioCryst, […]

Cerus Corporation (NASDAQ:CERS) Announces Amended Growth Capital Deal

Cerus Corporation (NASDAQ:CERS) reported that it has finalized a $40 million amended growth capital agreement with Oxford Finance LLC, a firm that offers senior debt to healthcare services and life sciences firms globally. Under the amended facility, the company obtained an immediate loan of $30 million at closing on July 2017 and has the alternative […]

Oclaro, Inc. (NASDAQ:OCLR) Appoints Ian Small To Lead Global Communications Services

Oclaro, Inc. (NASDAQ:OCLR) recently appointed Ian Small as a new member to its board of directors to lead the Company’s global communications services. The appointment is effective from September 1. Small has extensive experience in leading the communication services across the world and has worked with several companies as an executive and technology strategist and […]

Sign Up To Get Our Latest Stocks Alerts